X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21433) 21433
Book Chapter (179) 179
Publication (56) 56
Dissertation (45) 45
Conference Proceeding (16) 16
Government Document (13) 13
Magazine Article (5) 5
Newsletter (4) 4
Newspaper Article (3) 3
Journal / eJournal (2) 2
Paper (2) 2
Web Resource (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
radical prostatectomy (17378) 17378
humans (14943) 14943
male (14307) 14307
prostate cancer (11708) 11708
urology & nephrology (9781) 9781
aged (7962) 7962
middle aged (7942) 7942
prostatic neoplasms - pathology (6053) 6053
oncology (5723) 5723
cancer (5637) 5637
prostatic neoplasms - surgery (5068) 5068
prostatectomy (4300) 4300
surgery (3554) 3554
men (3239) 3239
prostate-specific antigen - blood (3214) 3214
treatment outcome (2961) 2961
radiotherapy (2943) 2943
urology (2905) 2905
prognosis (2777) 2777
care and treatment (2618) 2618
carcinoma (2615) 2615
retrospective studies (2532) 2532
prostate (2496) 2496
neoplasm staging (2460) 2460
aged, 80 and over (2388) 2388
prostatectomy - methods (2387) 2387
prostatic neoplasms - therapy (2364) 2364
adult (2294) 2294
prostatic neoplasms - diagnosis (2194) 2194
risk factors (2154) 2154
biopsy (2153) 2153
prostatic neoplasms - radiotherapy (2140) 2140
outcomes (2057) 2057
prostatic neoplasms - blood (2033) 2033
radiation-therapy (1919) 1919
survival (1906) 1906
research (1887) 1887
radiology, nuclear medicine & medical imaging (1879) 1879
risk (1844) 1844
diagnosis (1838) 1838
analysis (1835) 1835
antigen (1722) 1722
prostatic neoplasms - mortality (1717) 1717
prostate-specific antigen (1670) 1670
health aspects (1653) 1653
follow-up studies (1647) 1647
quality-of-life (1524) 1524
prostate - pathology (1495) 1495
adenocarcinoma (1486) 1486
mortality (1474) 1474
prostatic neoplasms (1466) 1466
recurrence (1437) 1437
radical retropubic prostatectomy (1428) 1428
prostatectomy - adverse effects (1409) 1409
quality of life (1358) 1358
therapy (1356) 1356
progression (1340) 1340
biochemical recurrence (1325) 1325
prospective studies (1283) 1283
medicine & public health (1281) 1281
time factors (1264) 1264
laparoscopy (1249) 1249
disease-free survival (1145) 1145
neoplasm grading (1139) 1139
female (1129) 1129
metastasis (1110) 1110
abridged index medicus (1065) 1065
predictive value of tests (1054) 1054
management (1040) 1040
impact (1039) 1039
brachytherapy (1035) 1035
follow-up (1009) 1009
active surveillance (980) 980
pathology (970) 970
gleason score (967) 967
prostatic neoplasms - drug therapy (953) 953
erectile dysfunction (945) 945
risk assessment (927) 927
disease progression (922) 922
patients (892) 892
patient outcomes (884) 884
complications (880) 880
usage (870) 870
radiation therapy (864) 864
experience (857) 857
oncology, experimental (857) 857
multivariate analysis (855) 855
magnetic resonance imaging (833) 833
tumors (831) 831
robotics (800) 800
medicine, general & internal (799) 799
robotic surgery (785) 785
radiation (784) 784
androgen antagonists - therapeutic use (780) 780
prostatic neoplasms - epidemiology (778) 778
urinary incontinence (771) 771
prostatic neoplasms - metabolism (762) 762
survival rate (762) 762
sensitivity and specificity (761) 761
prostatic neoplasms - diagnostic imaging (760) 760
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19984) 19984
German (688) 688
French (666) 666
Spanish (449) 449
Japanese (143) 143
Portuguese (140) 140
Russian (135) 135
Turkish (37) 37
Italian (19) 19
Hungarian (18) 18
Dutch (16) 16
Chinese (8) 8
Polish (8) 8
Korean (7) 7
Czech (6) 6
Swedish (5) 5
Lithuanian (4) 4
Norwegian (3) 3
Croatian (2) 2
Hebrew (2) 2
Persian (2) 2
Slovak (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European urology, ISSN 0302-2838, 2016, Volume 70, Issue 5, pp. 846 - 853
Journal Article
Clinical cancer research, ISSN 1557-3265, 2017, Volume 23, Issue 9, pp. 2169 - 2176
.... We evaluated neoadjuvant therapy prior to prostatectomy with the potent AR antagonist enzalutamide (enza... 
THERAPY | ANTIANDROGEN | ONCOLOGY | RESISTANCE | PHASE-II | RADICAL PROSTATECTOMY | INCREASED SURVIVAL | CANCER | CHEMOTHERAPY | PROGRESSION | ABIRATERONE | Neoplasm, Residual - pathology | Phenylthiohydantoin - adverse effects | Prostatic Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prostatic Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Combined Modality Therapy | Neoplasm, Residual - blood | Phenylthiohydantoin - analogs & derivatives | Prostate-Specific Antigen - blood | Phenylthiohydantoin - administration & dosage | Receptors, Androgen - genetics | Leuprolide - administration & dosage | Neoadjuvant Therapy - adverse effects | Prostatic Neoplasms - blood | Prostatectomy | Aged | Neoplasm, Residual - chemically induced | Dutasteride - administration & dosage | Prostatic Neoplasms - drug therapy | Therapy | Health risks | Minimal residual disease | Patients | Anticancer properties | Testosterone | Signaling | Dihydrotestosterone | Androgens | Flutamide | Experimental design | Luteinizing hormone | Luteinizing hormone-releasing hormone | Antitumor activity | Prostate cancer | Prostate | Cancer | dutasteride | neoadjuvant | NEW MOLECULAR TARGETS | THERAPEUTICS: Cellular responses to anticancer drugs | CL01 PHASE I – III CLINICAL TRIALS: Phase I–III Trials_Genitourinary cancers: prostate | ET02 MECHANISMS OF DRUG ACTION | enzalutamide
Journal Article
European urology, ISSN 0302-2838, 2015, Volume 67, Issue 4, pp. 660 - 670
Journal Article